Financials
- Market Capitalization 211.96 M
- Employee 235
- Founded 1983
- CEO N/A
- Website www.anika.com
- Headquarter Delaware, United States
- FIGI BBG000BBKZD8
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3385 | TKNO Alpha Teknova, Inc. - Common Stock | 5.29 USD | -2.22% | +2.32% | +14.75% | +23.60% | 283.62 M USD | ||
| 3459 | SIGA SIGA Technologies Inc. - Common Stock | 3.56 USD | +4.09% | 0.00% | -17.59% | -58.12% | 255.34 M USD | ||
| 3631 | DERM Journey Medical Corporation - Common Stock | 7.27 USD | +2.11% | +7.70% | +18.02% | +1.39% | 200.18 M USD | ||
| 3684 | LFCR Lifecore Biomedical, Inc. - Common Stock | 4.86 USD | +5.42% | +3.40% | -8.99% | -36.22% | 182.30 M USD |
Frequently asked questions about Anika Therapeutics Inc. - Common Stock
What is the Anika Therapeutics Inc. - Common Stock stock price today?
The current price of Anika Therapeutics Inc. - Common Stock (ANIK) is 15.93. Over the past 24 hours, the stock has changed by +2.64%. Follow the ANIK chart for real-time price dynamics.
What is the stock ticker of Anika Therapeutics Inc. - Common Stock?
Anika Therapeutics Inc. - Common Stock trades under the ticker ANIK. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Anika Therapeutics Inc. - Common Stock stock going up?
ANIK has changed by -2.21% over the last week, +10.62% over the last month, and +57.10% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Anika Therapeutics Inc. - Common Stock net income for the last quarter?
Anika Therapeutics Inc. - Common Stock reported net income of -5.06 M for the last quarter. The previous quarter showed 292 K, which means net income changed by -1831.51%.
How many employees does Anika Therapeutics Inc. - Common Stock have?
As of the latest available data, Anika Therapeutics Inc. - Common Stock has 235 employees. Workforce size can provide additional context about the company's scale and operations.
What is Anika Therapeutics Inc. - Common Stock EBITDA?
Anika Therapeutics Inc. - Common Stock EBITDA is 6.53 M, and its EBITDA margin is 22.04%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Anika Therapeutics Inc. - Common Stock stock?
You can buy Anika Therapeutics Inc. - Common Stock (ANIK) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Anika Therapeutics Inc. - Common Stock stock?
Investing in Anika Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ANIK chart and related analysis on metatrader.com as part of your research.